A recent study showed that patients with biochemical PCa recurrence and treated with salvage radiation therapy (SRT) have a long term disease-free rate which rapidly declines with increasing levels of PSA at treatment start [5]. This evidence concerns the gene KLK3 and posterior cortical atrophy.